Synthesis and Pharmacological Evaluation of Some Novel Imidazole Derivatives for Their Potential Anti-hypertensive Activity

Authors

  • Anju GoyalChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
  • Jitender SinghLord Shiva College of Pharmacy, Sirsa, Haryana, INDIA
  • Dharam Pal PathakDelhi Institute of Pharamceutical Sciences And Research, New Delhi, INDIA
Keywords
Synthesis, benzimidazoles, anti-inflammatory activity, anti-convulasant activity

Abstract

Benzimidazole, which is a heterocyclic nucleus, plays an important role in various medicines. A number of therapeutic agents such as H1 antihistaminic agent clemizole, a potent opioid analgesic etonitazene, nonnucleoside antiviral compound enviroxime, for promotion of excretion of uric acid irtemazole, non sedating antihistaminic agent astemizole, anti ulcer drugs omeprazole and pentoprazole, antihelmintic thiabendazole, antinematodal nocodazole etc. are based on benzimidazole heterocyclic nucleus. The synthesis of various benzimidazole derivatives by the reaction of ortho phenylene diamine I with various organic acids to yield 2-substituted benzimidazole derivatives II which on further treatment with nitric acid and sulphuric acid yielded 5-nitro-2-substituted benzimdazoles III. Coupling of this compound with halogenated beta picoline V yielded the title compounds. The structures of synthesized compounds were elucidated mainly by spectral evidence. All the compounds were screened for their anti-hypertensive activity. The compounds exhibited moderate to signiicant activities.

References

  • Aranjo, C. V., Figneiredo, M. R., Kaplan, M. A., Lessa, M. A, Pimenta, D., Tibirica, E. (2008), ‘Antihypertensive effects of crude extracts from leaves of Echinodorus grandiflorus’, Fundam Clin Pharmacol. Vol. 22(2), pp 161-168. http://dx.doi.org/10.1111/j.1472-8206.2008.00565.x
  • Balakumar, P., Bali, A., Bansal, Y., Bansal, G., Kaur, G., Sugumaram, M., Singh, J. S., Sharma, A. and Singh, M (2005), ‘Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists’. Bioorg Med Chem Lett. Vol. 15(17), pp 3962-3965. http://dx.doi.org/10.1016/j.bmcl.2005.05.054
  • Bradhury, R.H., Pearce, R.J. and Rober, D.A. (1992), Chemical Abstract, 117, 111587.
  • Briseno, B. G., Nasser, H.and Salido, R. F., (1977), ‘Clinical evaluation of 1-beta-D-ribofuranosyl-1, 2, 4-triazole-3-carboxamide’. Ann N Y Acad Sci. Vol. 284, pp 272-277. http://dx.doi.org/10.1111/j.1749-6632.1977.tb21960.x
  • Castro, I.O and Galvao, P.A.A.( 1977), ‘The effect of l-β-D-ribofuranosyl-l,2,4-triazole-3-carboxamide on acute viral hepatitis’, Ann N Y Acad Sci. Vol. 284, pp 278-83. http://dx.doi.org/10.1111/j.1749-6632.1977.tb21961.x
  • Crestani, S., Gasparotto, F. M., Junior, A. G., Kassuya, C. A. L., Lourenco, E. L. B., Marques, M. C. A., Salvador, M. J., Santos, J. E. S., Stefanello, M. E. A. (2011), ‘Antihypertensive effects of isoquercitrin and extracts from Tropaeolum majus L.: Evidence for the inhibition of angiotensin converting enzyme’, J Ethnopharmacol. Vol. 134(2), pp 363-72. http://dx.doi.org/10.1016/j.jep.2010.12.026
  • Dureja, H., Kumar, V., Saggu, J. S. and Sharma, R. (2002), ‘Synthesis and Antihypertensive Activity of Some N-{4-(6-Chloro-5-nitro-1-[2’–(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1Hbenzoimidazol-2yl-}-phenyl)-3-(substituted-phenyl)-acryl amides’, Journal Indian Institute Science, Vol. 82, pp 172.
  • Fawzia, Z. E-Ablack (2011), ‘Synthesis of Some New Benzimidazole Derivatives of Pharmaceutical Interest’, E-Journal of Chemistry, Vol. 8, pp 748-752. http://dx.doi.org/10.1155/2011/723421
  • Freyne, E.J.E., Rayemakers, A.H.M., and Sanz, G.C., (1988), Chemical Abstract, 109: 73437.
  • Hamor, G.H. (1986), In: Principles of Medicinal Chemistry, Foye W.O. (Editor), Varghese Publishing House, Bombay, 3rd Edition, 503.
  • Hunger, A. and Kebrle, J. (1957), ‘Analgesics and their agonists’, Experientia Vol. 13(10), pp 400-1.
  • Ingle R.G. and Magar D.D. (2011),” Heterocyclic Chemistry of Benzimidazoles And Potential Activities Of Derivatives’, Int J Drug Res Tech, Vol. 1, pp 26-32
  • Jat, R.K., Jat, J.L. and Pathak, D.P. (2006),’ Synthesis of benzimidazole derivatives: As Antihypertensive agents, E- Journal of Chem, Vol. 3, pp 278.
  • Jerchee, D. and Leibigs, F. H. (1952), Annal. Chemie. Vol. 573, pp 173.
  • Kholer, P. (2001), ‘The biochemical basis of anthelmintic action and resistance’, International Journal of Parasitology, Vol. 31, pp 336.
  • Kumari, S., Kumar, P.S., Kumar,N. (2010), ‘Imidazole and its biological activities: A review’, Der Chemica Sinica, Vol. 1(3), pp 36-47.
  • Levin, J. I. and Venkatesan, A. M. (1944), Chemical Abstract, Vol. 120, pp 323589.
  • Lindberg, P. and Nordberg, P. (1986), ‘The mechanism of action of the gastric acid secretion inhibitor omeprazole’, J Med Chem, Vol. 29, pp 1327 . http://dx.doi.org/10.1021/jm00158a001
  • Olayinka, O. A., Emmanuel, K. E., Abiola Edobor-Osoh and Alice O. A. (2013), ‘Facile Synthesis and Characterization of New 2,3-Disubstituted Benzimidazole Derivatives’, Int Res Pure & App Chem, Vol. 3(1), pp 10-21. http://dx.doi.org/10.9734/IRJPAC/2013/2480
  • Pandey, V.K., Gupta, V.D. and Tiwari, D.N. (2005), ‘Synthesis of Novel Pyrazolidine Dione Substituted Benzimidazole Derivatives And Their Biological Activity’, Ind Hetero Chem, Vol. 14, pp 219.
  • Shah, D., Sharma, M., Bansal, Y., Bansal, G. and Singh, M. (2007), ‘Angiotensin II–AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives’, Eur J Med Chem, Vol. 20, pp 1-5.
  • Walia, R., Md. Hedaitullah1, Naaz, S. F., Iqbal, K., and. Lamba, HS. (2011),’ Benzimidazole Derivatives – An Overview’. Int Res Phar Chem, Vol. 3, pp 565-564.

How to Cite

Anju Goyal, Jitender Singh, Dharam Pal Pathak. Synthesis and Pharmacological Evaluation of Some Novel Imidazole Derivatives for Their Potential Anti-hypertensive Activity. J. Pharm. Technol. Res. Manag.. 2013, 01, 69-79
Synthesis and Pharmacological Evaluation of Some Novel Imidazole Derivatives for Their Potential Anti-hypertensive Activity

Current Issue

PeriodicityBiannually
Issue-1May
Issue-2November
ISSN Print2321-2217
ISSN Online2321-2225
RNI No.CHAENG/2013/50088
OA Policy

Publisher's policy of the journal at Sherpa UK for the submitted, accepted, and published articles. Click OAPolicy

Plan-S Compliance

To check compliance, one has to use the Journal Check Tool (JCT). This tool provided by cOAlition S (European funders) for the researchers (fundee) to check the compliance with the journal.

Recommend journal to your library

You can recommend the journal being a researcher or faculty member to your library. We will post a copy of the Journal to your library on your behalf at free of cost.
Click here: Recommend Journal

Preprint Arxiv Submission

The authors are encouraged to submit the author’s copy (preprint) to appropriate preprint archives e.g. https://arxiv.org and/or on https://indiarxiv.org or institutional repositories (e.g., D Space) before paper acceptance by the editor of Journal. After publications of the paper author(s) should mention the citation information, title and abstract along with DOI number of the publication carefully on the required page of the depository(ies).

Contact: Phone: +91-172-2741000, +91-172-4691800

Email : editor.jptrm@chitkara.edu.in;

Abstract and Indexing

Information

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles in Journal of Pharmaceutical Technology, Research and Management (J. Pharm. Tech. Res. Management) by Chitkara University Publications are Open Access articles that are published with licensed under a Creative Commons Attribution- CC-BY 4.0 International License. Based on a work at https://jptrm.chitkara.edu.in/. This license permits one to use, remix, tweak and reproduction in any medium, even commercially provided one give credit for the original creation.

View Legal Code of the above-mentioned license, https://creativecommons.org/licenses/by/4.0/legalcode

View Licence Deed here https://creativecommons.org/licenses/by/4.0/

Creative Commons License

Journal of Pharmaceutical Technology, Research and Management by Chitkara University Publications is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://jptrm.chitkara.edu.in//

Members